You can purchase shares of Immunome (NASDAQ:IMNM) through any online brokerage.

View our list of the best stock brokerages

Other companies in Immunome’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Legend Biotech Corp (NASDAQ:LEGN), Twist Bioscience Corp (NASDAQ:TWST), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) and Ascentage Pharma Group International (NASDAQ:AAPG).

Immunome has a consensus price target of $26.00.

The stock price for Immunome (NASDAQ: IMNM) is $24.69 last updated February 10, 2026 at 12:34 PM EST.

There are no upcoming dividends for Immunome.

Immunome does not have any upcoming earnings scheduled.

There is no upcoming split for Immunome.

Immunome is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.